Skip to main content
HR 2071 117th Congress House Health Health care costs and insurance Inflation and prices Medicare Prescription drugs Public contracts and procurement

Medicare Prescription Drug Price Negotiation Act of 2021

Introduced: March 18, 2021 Introduced by: Welch, Peter Democratic · Vermont See on congress.gov
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 19, 2021
Referred to the Subcommittee on Health.
Mar 18, 2021
Introduced in House
Mar 18, 2021
Referred to the Subcommittee on Health.
Mar 18, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
 Plain-English summary Congressional Research Service

Medicare Prescription Drug Price Negotiation Act of 2021

This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.

What's happening now March 19, 2021

Referred to the Subcommittee on Health.

 Committees of jurisdiction 4